Rajkummar Rao’s Prahaar – The Ujjwal Nikam Story has reached the fade-out stage of its theatrical run. On Thursday, November 5, the film added just Rs 1 lakh net in India, a 93.8% drop from the previous day, according to Sacnilk figures cited by The Times of India.
The 21-day picture
After three weeks, the courtroom drama has collected Rs 23.82 crore India net. Domestic gross stands at Rs 28.24 crore, and worldwide gross is Rs 30.83 crore. Overseas markets have contributed Rs 3.03 crore, or 9.8% of the global total. India is doing the heavy lifting with 90.2% of worldwide revenue.
A week-over-week fade
The weekly curve is the more useful number for the trade than the cumulative total:
- Opening week: Rs 17.15 crore net
- Week two: Rs 4.50 crore net, a 73.8% decline
- Week three: Rs 2.17 crore net, a further 51.8% decline
- Day 21: Rs 1 lakh net, 17 shows nationwide, 23% occupancy
Across 21 days, the film has logged 37,714 shows. The current show count tells the story: at 17 shows on Thursday, the release is no longer holding a meaningful theatrical footprint.
What the fade-out says for planners
Prahaar is a front-loaded niche title. Its opening week was strong enough to produce Rs 17.15 crore, but the following weeks show the audience did not expand. For media planners and distribution teams, that is the pattern to model: a known face and a courtroom premise can deliver an initial sampling, but without broader word-of-mouth, the tail collapses quickly.
The film stars Rajkummar Rao as public prosecutor Ujjwal Nikam, with Wamiqa Gabbi, Jaideep Ahlawat and Sikandar Kher in important roles. The story revisits the legal proceedings connected to the 1993 Bombay Blasts and the 2008 Mumbai Train Attacks.
None of this makes the film a write-off by itself; the cumulative Rs 23.82 crore is still the number distributors will quote. But the direction of travel matters more. When a release drops to 17 shows and a single lakh on a weekday, every additional day is marginal.
The next box office milestone is unlikely to move much; the number worth tracking now is the streaming licensing outcome, where a niche courtroom title may find a longer shelf life than it did in theatres.
Source: The Times of India
